<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-37515" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cardiac Disease in Pregnancy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Iftikhar</surname>
            <given-names>Syed F.</given-names>
          </name>
          <aff>UC Riverside/Riverside Community Hospt.</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Biswas</surname>
            <given-names>Mimi</given-names>
          </name>
          <aff>Unversity of California, Riverside</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Iftikhar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mimi Biswas declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-37515.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Many cardiac diseases during pregnancy are under investigation, and many others which are still not understood require further inquiry. Some of these diseases may be exacerbations of pre-existing conditions that the pregnant woman may already have, or they may develop a new disease process that presents because of the complex hormonal changes and physiology of pregnancy. Preexisting conditions that can predispose pregnant women to cardiovascular disease include hypertension, diabetes mellitus, and congenital heart disease. This activity reviews the evaluation of cardiac disease in pregnancy and identifies the role of the interprofessional team in managing this condition. </p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the cause of heart disease in pregnancy.</p></list-item><list-item><p>Describe the pathophysiology of heart disease in pregnancy.</p></list-item><list-item><p>Explain the treatment of heart disease in pregnancy.</p></list-item><list-item><p>Summarize the evaluation of cardiac disease in pregnancy and identify the role of the interprofessional team in managing this condition. </p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37515&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37515">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-37515.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cardiac disease of pregnancy encompasses a broad arena of pathologies. Many cardiac diseases during pregnancy are under investigation, and many others which are still not understood require further inquiry. Some of these diseases may be exacerbations of pre-existing conditions that the pregnant woman may already have, or they may develop a&#x000a0;new disease process that presents because of the complex hormonal changes and physiology of pregnancy. Pre-existing conditions that can predispose pregnant women to cardiovascular disease include hypertension, diabetes mellitus, and congenital heart disease.<xref ref-type="bibr" rid="article-37515.r1">[1]</xref>&#x000a0;Regardless, cardiac disease of pregnancy is a significant cause of or morbidity and mortality and has been cited to be present between 1 to 4% of all pregnancies.<xref ref-type="bibr" rid="article-37515.r2">[2]</xref>&#x000a0;Although there is a significant risk involved with such pregnancies, one can successfully treat the majority of these incidents if early detection and careful follow-up are a part of routine care.</p>
      </sec>
      <sec id="article-37515.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of cardiovascular diseases of pregnancy is variable and dependent on the pathology involved. The following summarizes some common cardiovascular diseases of pregnancy and their hypothesized etiologies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiomyopathy: There are several hypotheses regarding the etiology of this disease process. Some of the most common theories are viral myocarditis, autoimmune causes, hemodynamic instability, microchimerism, as well as others.<xref ref-type="bibr" rid="article-37515.r3">[3]</xref>&#x000a0;It is important to note that the risk factors which exist towards causing cardiomyopathy in non-pregnant individuals continue to exist during pregnancy and the weeks following pregnancy, and the heart may even be at higher susceptibility to these exposures. These causes include alcohol abuse, doxorubicin use, and abuse of drugs such as cocaine and methamphetamines.<xref ref-type="bibr" rid="article-37515.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Coronary artery disease: The etiology of ischemic heart disease in pregnant women is similar to that of non-pregnant women. Risk factors that expose these individuals to ischemic heart disease include hypertension, hyperlipidemia and hypertriglyceridemia, diabetes mellitus, obesity, smoking, and immobility.<xref ref-type="bibr" rid="article-37515.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Pregnancy-associated myocardial infarction: The same risk factors for coronary artery disease also exist for pregnancy-associated MI. It has&#x000a0;been hypothesized that certain conditions of pregnancy, such as preeclampsia and eclampsia, could contribute to myocardial infarction.<xref ref-type="bibr" rid="article-37515.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Valvular disease: Although the hemodynamics of pregnancy can exacerbate certain valvular diseases, it is inconclusive whether pregnancy has a specific role in the etiology of newly diagnosed valvular disorders of pregnancy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37515.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The frequency of cardiac disease in women has not been clearly established. It is also unknown if there is an increased frequency of individuals in developed vs. under-developed countries. Based on the best data, estimates are that at least 0.2% of pregnancies have complications with cardiac disease.<xref ref-type="bibr" rid="article-37515.r7">[7]</xref>&#x000a0;This frequency has been reported&#x000a0;to be as high as 4%.<xref ref-type="bibr" rid="article-37515.r8">[8]</xref>&#x000a0;If one includes hypertensive disease in this value, this number would be even higher, given that hypertensive disorders have been approximated to occur in up to 8% of pregnancies.<xref ref-type="bibr" rid="article-37515.r8">[8]</xref></p>
      </sec>
      <sec id="article-37515.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The underlying physiology of pregnancy and the changes that occur are often a core aspect in promoting some of these disease processes of the heart. Speculations are that women may undergo these physiological changes as early as 5 weeks into their pregnancy.<xref ref-type="bibr" rid="article-37515.r9">[9]</xref>&#x000a0;It is essential to understand these changes and adaptations can vary among individuals. The belief is that many of these changes are the result of the attachment of the placenta to uterine walls, which induces the release of hormones and subsequent changes to maternal physiology. These changes are often hemodynamic and are counter-regulatory, and still, maintain the basic vascular principles of maintaining the new mean arterial pressure of pregnancy.<xref ref-type="bibr" rid="article-37515.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac output: Estimates for increases in a cardiac output range from 20 to 50%. These findings are seen within the first 5 weeks of gestation and increase until the late gestational age; this&#x000a0;is usually accounted for by an increased stroke volume of about 25% in the first trimester. This considerable increase in cardiac output is one reason why&#x000a0;pregnant women with pre-existing heart conditions can experience such dramatic effects, especially later on in pregnancy. Those with diseases such as cardiomyopathy may not adequately compensate for this stress and may develop complications such as pulmonary edema or fluid overloaded states.<xref ref-type="bibr" rid="article-37515.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Heart rate: Along with an increase in stroke volume, there is an increase in heart rate of approximately 15 to 30% in the first trimester of pregnancy, which also contributes to an increase in cardiac output.</p>
          </list-item>
          <list-item>
            <p>Systemic vascular resistance: Systemic vascular resistance decreases during pregnancy. Estimates are that this change may be as much as 30%. Some hormonal changes include decreased responsiveness of maternal vasculature to angiotensin II and norepinephrine.<xref ref-type="bibr" rid="article-37515.r12">[12]</xref> There is also an increased rate of release of vasodilators in the maternal female, such as prostaglandins and nitric oxide.<xref ref-type="bibr" rid="article-37515.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Blood pressure: Blood pressure slightly decreases early in pregnancy. Overall, more commonly, diastolic blood pressure decreases predominate over-systolic blood pressure early in pregnancy. Usually, this value normalizes or even increases by the end of pregnancy.</p>
          </list-item>
        </list>
        <p>A combination of the above physiological and hormonal changes are hypothesized as contributing to certain decompensated states of pregnancy, such as cardiomyopathy, congenital heart diseases, and valvular disease.&#x000a0;</p>
        <p>It is, however, without a doubt that specific structural changes occur to the maternal heart, and such changes can cause dysfunction in some of these pre-existing diseases. Because of the increase in the volume of pregnancy, a common effect is an enlargement of both atria and both ventricles by the end of pregnancy.<xref ref-type="bibr" rid="article-37515.r14">[14]</xref> &#x000a0;Left ventricular mass increases by up to 50% by the third trimester, and eccentric hypertrophy is also noted with increases in septal thickness.<xref ref-type="bibr" rid="article-37515.r15">[15]</xref> Some degree of&#x000a0;cardiac remodeling exists in the maternal heart, as many of the changes that occur to the maternal heart&#x000a0;are often seen to be reversed 6 to 8 months postpartum.<xref ref-type="bibr" rid="article-37515.r16">[16]</xref> For disease processes such as peripartum cardiomyopathy, it is easy to see why such dramatic changes would contribute to the exacerbation of disease processes. However, no specific studies have concluded the exact reason these females are much more vulnerable to this disease process than others. Therefore, theories such as concurrent myocarditis, an autoimmune phenomenon, or familial linkage are potential explanations for resultant peripartum cardiomyopathy.<xref ref-type="bibr" rid="article-37515.r17">[17]</xref>&#x000a0;In mouse models,&#x000a0;misregulation&#x000a0;of VEGF and angiogenesis have been theorized to have a vital role in this disease process.<xref ref-type="bibr" rid="article-37515.r18">[18]</xref></p>
        <p>Regarding pre-existing valvular disorders such as mitral stenosis, mitral regurgitation, aortic stenosis, and others, the chamber and valvular enlargement along with a potential volume overloaded state can contribute to morbidity and mortality. All of these conditions can contribute to the fluid overloaded state and place patients at risk for respiratory compromise and poorly perfused states.</p>
      </sec>
      <sec id="article-37515.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>An accurate history is essential towards diagnosing the various conditions heart conditions of pregnancy. Certain features which would lead to a consideration of cardiac disease would include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fatigue</p>
          </list-item>
          <list-item>
            <p>Shortness of breath</p>
          </list-item>
          <list-item>
            <p>Dyspnea on exertion</p>
          </list-item>
          <list-item>
            <p>Paroxysmal nocturnal dyspnea</p>
          </list-item>
          <list-item>
            <p>Orthopnea</p>
          </list-item>
          <list-item>
            <p>Increasing edema</p>
          </list-item>
          <list-item>
            <p>Chest pain or angina</p>
          </list-item>
          <list-item>
            <p>Lightheadedness</p>
          </list-item>
          <list-item>
            <p>Syncope</p>
          </list-item>
          <list-item>
            <p>Personal or familial history of heart disease especially in pregnancy</p>
          </list-item>
        </list>
        <p>&#x000a0;Physical exam findings would include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Tachycardia</p>
          </list-item>
          <list-item>
            <p>Hypotension</p>
          </list-item>
          <list-item>
            <p>Cyanosis</p>
          </list-item>
          <list-item>
            <p>Clubbing</p>
          </list-item>
          <list-item>
            <p>Jugular venous distension</p>
          </list-item>
          <list-item>
            <p>Rales</p>
          </list-item>
          <list-item>
            <p>Ascites</p>
          </list-item>
          <list-item>
            <p>Hepatomegaly</p>
          </list-item>
          <list-item>
            <p>Peripheral edema</p>
          </list-item>
          <list-item>
            <p>S3&#x000a0;</p>
          </list-item>
          <list-item>
            <p>S4&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hepatojugular reflux</p>
          </list-item>
          <list-item>
            <p>Prominent a and v waves</p>
          </list-item>
          <list-item>
            <p>Shifted apical impulse laterally to the midclavicular line</p>
          </list-item>
          <list-item>
            <p>Gallop</p>
          </list-item>
        </list>
        <p>Many of these findings can also be present in normal pregnancy; thus it is a challenge for the clinician to identify which of these processes are physiologic and which are pathologic. A combination of history and physical elements is critical to further delineate between these two.</p>
      </sec>
      <sec id="article-37515.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluation of cardiac disease in pregnant females will often require advanced workup. Initial basic workup with labs such as CBC, CMP, and urinalysis can give necessary clues to underlying processes that may be occurring. Elevated white blood cell count can help test for inflammatory conditions of the heart, such as myocarditis or myocardial infarction. Routine serum creatinine measurement can help the provider test if the patient has had periods of hypo-perfusion in recent history. Liver enzymes could help identify congestive hepatopathy as they would in non-pregnant individuals. Urinalysis could reveal protein to help identify a state of pre-eclampsia. Labs such as brain natriuretic peptide (BNP) may have utility as some note to double during pregnancy.<xref ref-type="bibr" rid="article-37515.r19">[19]</xref> Still, those who have overt peripartum cardiomyopathy have been found to have higher levels of BNP&#x000a0;than those who do not.</p>
        <p>An electrocardiogram&#x000a0;may be done and reveal various findings as well, similar to those who have cardiovascular disease outside of pregnancy. Normal heart changes in pregnancy will cause rotation of the heart to the left and a resultant mild left axis deviation. As previously mentioned, dilation of all chambers of the heart occurs in pregnancy, and thus this predisposes these individuals to develop dysrhythmias. Some of the most common dysrhythmias seen in pregnancy include atrial premature beats, supraventricular tachycardias, and ventricular premature beats.<xref ref-type="bibr" rid="article-37515.r20">[20]</xref><xref ref-type="bibr" rid="article-37515.r21">[21]</xref> Ventricular tachyarrhythmias may also form but are much rarer.<xref ref-type="bibr" rid="article-37515.r22">[22]</xref>&#x000a0;If an individual is undergoing ischemic changes, one would expect to find ECG&#x000a0;changes consistent with an ischemic burden, including ST-elevations or depressions, T-wave inversion, or formation of Q-waves. Non-specific changes to ST-segment or T-waves present in up to 14% of pregnancies.<xref ref-type="bibr" rid="article-37515.r23">[23]</xref></p>
        <p>An echocardiogram is essential for evaluating those undergoing cardiac insults of pregnancy. Physiologic findings may reveal chamber enlargement, physiologic aortic, mitral, tricuspid regurgitation, and valvular dilatation.<xref ref-type="bibr" rid="article-37515.r24">[24]</xref>&#x000a0;Clinical manifestations of these processes, along with the degree of echocardiographic findings, will require evaluation by a clinician to evaluate their significance. No strict cutoff for each of these has been deemed &#x0201c;normal&#x0201d; or &#x0201c;abnormal&#x0201d; in pregnancy. Findings of cardiomyopathy may reveal exaggerated septal thickening, end-diastolic posterior wall thickening, and resultant eccentric hypertrophy.<xref ref-type="bibr" rid="article-37515.r25">[25]</xref>&#x000a0;Echocardiography can diagnose peripartum cardiomyopathy if the ejection fraction is less than 45% and/or M-mode shortening below 30%, and end-diastolic dimension is greater than 2.7cm/m2.<xref ref-type="bibr" rid="article-37515.r26">[26]</xref> Localized wall motion abnormalities may present in myocardial ischemia or infarction. Pericardial effusion may also be evident in pregnancy and, in small amounts, can be physiologic; however, if the patient is exhibiting signs of hypotension, JVD, or pulsus paradoxus, then evaluation of tamponade should be undertaken with echocardiography.</p>
      </sec>
      <sec id="article-37515.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are no recommended empiric regimens towards preventing cardiac disease in pregnancy. Those who have a prior history of cardiac disease should merit increased vigilance, and these individuals should continue their prior regimen. If such regimens contain teratogenic drugs, a qualified provider should substitute these medications. Treatment modalities for cardiac disease of pregnancy vary based upon the disease process occurring and required an individualized approach. The following discusses some common cardiac disorders and their appropriate recommended treatment regimens:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ventricular dysfunction of pregnancy: Many females enter pregnancy with previous heart failure. These individuals may be aware or unaware of these before pregnancy based upon the level of function. The physiologic changes of pregnancy can prove challenging for these patients to compensate. By the time these physiologic changes of pregnancy (increased heart rate, increased circulating volume) are in full effect in the second trimester, these pregnant patients may experience a severe exacerbation of their underlying disease. Besides angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, other medications used to treat heart failure can be resumed. ACE&#x02019;s and ARB&#x02019;s which are often a mainstay of treatment in heart failure with reduced ejection fraction, are known to be teratogenic with reported effects of renal dysplasia, renal failure, oligohydramnios, and intrauterine growth retardation.<xref ref-type="bibr" rid="article-37515.r27">[27]</xref>&#x000a0;A&#x000a0;combination of hydralazine and nitrates can be used instead to elicit a similar effect. Beta-blockers may&#x000a0;be continued,&#x000a0;with a preference for&#x000a0;cardio-selective beta-blockers such as metoprolol. If&#x000a0;diuretics are required, they may&#x000a0;be continued.<xref ref-type="bibr" rid="article-37515.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Peripartum cardiomyopathy is a dilated cardiomyopathy that presents in the last 4 weeks of pregnancy or up to 5 months postpartum will require a similar treatment regimen to those with ventricular dysfunction of pregnancy.<xref ref-type="bibr" rid="article-37515.r29">[29]</xref> An exception is with a diagnosis of peripartum cardiomyopathy; ACE inhibitors or ARB therapy may resume after delivery.</p>
          </list-item>
          <list-item>
            <p>Mitral stenosis: The obstructive nature of mitral stenosis results in high&#x000a0;morbidity and mortality in pregnant patients.<xref ref-type="bibr" rid="article-37515.r30">[30]</xref> There are no medications shown to reverse this disease in these individuals; however, beta-blockers remain the medication of choice. Beta-blockers are thought to decrease trans-mitral gradient.<xref ref-type="bibr" rid="article-37515.r31">[31]</xref>&#x000a0;Diuretics are also useful for heart failure symptoms.</p>
          </list-item>
          <list-item>
            <p>Aortic stenosis: Although aortic stenosis in pregnancy is less common, it is often more challenging to treat. Just as in aortic stenosis in non-pregnant individuals, there are no medications that reverse the disease or are mainstays of treatment. Beta-blockers are not as effective as they are mitral stenosis in reducing trans-valvular gradient. Ace inhibitors are contraindicated in pregnant patients. Diuretic therapy necessitates caution because of&#x000a0;the potential of reduced diastolic filling and further diminished cardiac output.</p>
          </list-item>
          <list-item>
            <p>Tachyarrhythmias: Tachyarrhythmias require treatment on an individualized basis. However, drugs that appear to be safe to use in pregnant women with tachyarrhythmias include adenosine, verapamil, digoxin, flecainide, and beta-blockers.<xref ref-type="bibr" rid="article-37515.r32">[32]</xref>&#x000a0;Amiodarone should be avoided, given its proclivity to cause fetal hypothyroidism.<xref ref-type="bibr" rid="article-37515.r33">[33]</xref></p>
          </list-item>
          <list-item>
            <p>Spontaneous Coronary Artery Dissection (SCAD): This is an atypical cause of acute MI. Its incidence, however, increases in pregnant women. Spontaneous coronary artery dissection should be considered in any pregnant female presenting with symptoms consistent with acute coronary syndrome. <xref ref-type="bibr" rid="article-37515.r34">[34]</xref> This dissection usually affects the left main or the left anterior descending artery. <xref ref-type="bibr" rid="article-37515.r35">[35]</xref> SCAD is believed to be secondary to the hormonal changes of pregnancy, as well as hemodynamic changes which cause arterial wall weakening.&#x000a0; This is further hypothesized to include inflammatory infiltrates <xref ref-type="bibr" rid="article-37515.r36">[36]</xref>. Diagnosis may be made using coronary angiography. Management,&#x000a0;however, has not been standardized due to its rarity. Many different management strategies have been utilized. These include heart transplantation, coronary artery bypass grafting (CABG), or medical management. <xref ref-type="bibr" rid="article-37515.r37">[37]</xref> CABG may be the treatment modality of choice if multiple arteries have undergone dissection, in those with left main stem dissection, or in those who have failed PCI. <xref ref-type="bibr" rid="article-37515.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Acute coronary syndrome: ACS and MI are uncommon in pregnant women; however, given the increasing average age of that women are becoming pregnant, it is becoming more common. Advanced age allows the risk factors towards developing ACS to develop. These risk factors include diabetes mellitus, hyperlipidemia, and hypertension. Exposure to fluoroscopy for a pregnant mother is not ideal; however, given the high mortality with acute coronary syndromes, PCI should be attempted with a lead covering the mother. Thrombolysis is also an option; however, it must be administered under close monitoring, given the documented reports of maternal hemorrhage, spontaneous abortion, subchorionic hematomas, and uterine bleeding.<xref ref-type="bibr" rid="article-37515.r39">[39]</xref>&#x000a0;Drug-eluting stents should be avoided if possible because of the prolonged need for dual antiplatelet therapy. Given the increasing incidence of cesarian sections deliveries, dual antiplatelet therapy might be problematic.<xref ref-type="bibr" rid="article-37515.r40">[40]</xref>&#x000a0;A list of commonly used drugs and their pregnancy category class are listed below.<xref ref-type="bibr" rid="article-37515.r40">[40]</xref>
<list list-type="bullet"><list-item><p>Morphine (Risk Category C)</p></list-item><list-item><p>Beta-blockers(Category B: metoprolol; Category C: atenolol)</p></list-item><list-item><p>Calcium channel blockers: (Category C)</p></list-item><list-item><p>Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) (Category C in the first trimester and Category D in the second and third trimester)</p></list-item><list-item><p>Statins&#x000a0;(Risk Category X)</p></list-item><list-item><p>Unfractionated&#x000a0;heparin (Category C)</p></list-item><list-item><p>Low-molecular-weight heparin (&#x000a0;Category B)</p></list-item><list-item><p>Aspirin (Category C)</p></list-item><list-item><p>Glycoprotein IIb/IIIa inhibitors (Category B: eptifibatide, tirofiban; &#x000a0;Category C: abciximab)</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Those who present with blood pressure greater than 160/100 should receive antihypertensive therapy with close monitoring in the clinic or even in the hospital-based on severity. <xref ref-type="bibr" rid="article-37515.r41">[41]</xref> Some common anti-hypertensive agents which have been shown to be safe in pregnancy include:
<list list-type="bullet"><list-item><p>Methyldopa (oral)</p></list-item><list-item><p>Labetalol (oral/IV)</p></list-item><list-item><p>Nifedipine (oral)</p></list-item><list-item><p>Hydralazine (oral/IV)</p></list-item><list-item><p>Nicardipine (IV</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37515.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Cardiac diseases of pregnancy need evaluation as new processes or exacerbations of previous disease processes. With any cardiac disease process detected in pregnancy, the preexisting pathology must be ruled out. Such include prior dilated cardiomyopathy, restrictive cardiomyopathy, hypertensive obstructive cardiomyopathy, ischemic heart disease, or previous valvular disorders.</p>
      </sec>
      <sec id="article-37515.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The World Health Organization has established a modified classification of maternal cardiovascular risk. This is used as a tool to evaluate risk status for pregnant females with various cardiovascular conditions. The classifications are as follows.</p>
        <list list-type="bullet">
          <list-item>
            <p>I: No Identifiable elevated risk of maternal morbidity/mortality</p>
          </list-item>
          <list-item>
            <p>II: Mildly elevated maternal mortality; moderate elevation of morbidity</p>
          </list-item>
          <list-item>
            <p>III: Substantially elevated risk in maternal mortality; severely elevation of morbidity. For these patients, it is recommended that close follow-up be initiated with cardiac specialists. Cardiac monitoring should continue regularly throughout pregnancy and should also continue after pregnancy.</p>
          </list-item>
          <list-item>
            <p>IV: Extremely elevated risk of maternal mortality; severe elevation of morbidity. Pregnancy is contraindicated for these individuals. If pregnancy is to occur, termination should be recommended. However, if the individual chooses to pursue pregnancy, she should be monitored closely as class III individuals.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>WHO Class I Conditions</bold>:
<list list-type="bullet"><list-item><p>Uncomplicated or mild
<list list-type="order"><list-item><p>Patient ductus arterosisi</p></list-item><list-item><p>Pulmonic stenosis</p></list-item><list-item><p>Mitral valve prolapse repaired ventricular septal defect</p></list-item></list>
</p></list-item><list-item><p>Repaired atrial septal defect</p></list-item><list-item><p>Repair ventricular septal defect</p></list-item><list-item><p>Repaired anomalous pulmonary venous drainage</p></list-item><list-item><p>Repaired patent ductus arteriosus</p></list-item><list-item><p>Atrial ectopic beats</p></list-item><list-item><p>Ventricular ectopic beats&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>WHO Class II Conditions:</bold>
</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Unrepaired atrial septal defect</p>
              </list-item>
              <list-item>
                <p>Unrepaired ventricular defect</p>
              </list-item>
              <list-item>
                <p>Repaired tetralogy of Fallot</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>WHO II/II based on individual</bold>
<list list-type="bullet"><list-item><p>Mild left ventricle compromise</p></list-item><list-item><p>Repaired coarctation of the aorta</p></list-item><list-item><p>Hypertrophic obstructive cardiomyopathy</p></list-item><list-item><p>Marfan syndrome without aortic dilation</p></list-item><list-item><p>Bicuspid aortic valve with aorta &#x0003c;45 mm</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>WHO Class III Conditions</bold>
<list list-type="bullet"><list-item><p>Mechanical valve</p></list-item><list-item><p>Fontan circulation</p></list-item><list-item><p>Unrepaired cyanotic heart defects</p></list-item><list-item><p>Systemic right ventricle</p></list-item><list-item><p>Marfan syndrome with aorta dilated to 40 to 45 mm</p></list-item><list-item><p>Bicuspid aortic valve with aorta dilated to 45 to 50 mm</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>WHO Class IV Conditions</bold>
<list list-type="bullet"><list-item><p>Pulmonary arterial Hypertension (any class)</p></list-item><list-item><p>Severe left ventricular compromise (ejection fraction &#x0003c;30%)</p></list-item><list-item><p>Prior peripartum cardiomyopathy, especially if remaining impairment</p></list-item><list-item><p>Severe mitral stenosis</p></list-item><list-item><p>Severe aortic stenosis</p></list-item><list-item><p>Marfan syndrome with aortic dilatation &#x0003e;45 mm</p></list-item><list-item><p>Bicuspid aortic valve disease with aortic dilatation &#x0003e;50 mm</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Although heart disease in pregnancy is a high-risk state, successful outcomes are possible and even common in patients that have a regular follow-up. Some conditions of pregnancy carry more morbidity and mortality than others, however.</p>
        <list list-type="bullet">
          <list-item>
            <p>Peripartum cardiomyopathy: Peripartum cardiomyopathy occurs in approximately 1 in 2289 live births. About 75% of women with this disease process have a full return of normal ventricular function.<xref ref-type="bibr" rid="article-37515.r42">[42]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Congenital heart defects: Regurgitant lesions have improved morbidity over stenotic lesions. Overall, however, mortality is negligible in patients with congenital heart disease, with one study identifying no maternal deaths in an analysis of 90 individuals.<xref ref-type="bibr" rid="article-37515.r43">[43]</xref>&#x000a0;The same study did, however, report that 17% of these patients had pulmonary edema, and 12% had cardiac events (mostly nonsustained tachyarrhythmia). A meta-analysis of over 2000&#x000a0; pregnancies revealed a spontaneous abortion rate of 15%. However, this study found an 8% incidence of congenital heart disease in the offspring.<xref ref-type="bibr" rid="article-37515.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Acute coronary syndrome: ACS and MI are rare in pregnancy, with some estimates reporting 1 to 2 per 35000 deliveries.<xref ref-type="bibr" rid="article-37515.r40">[40]</xref>&#x000a0;In a study looking at the prognosis of pregnancies with coronary artery disease or acute coronary syndromes, 16% of adverse obstetric events occurred, while it reported 30% adverse neonatal events.<xref ref-type="bibr" rid="article-37515.r45">[45]</xref> Reported maternal mortality is 7.3%, with the highest risk of this for those who present with ACS in the third trimester.<xref ref-type="bibr" rid="article-37515.r46">[46]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37515.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications related to cardiac disease in pregnancy include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Excess weight gain&#x000a0;during pregnancy</p>
          </list-item>
          <list-item>
            <p>Preeclampsia</p>
          </list-item>
          <list-item>
            <p>Preterm&#x000a0;birth</p>
          </list-item>
          <list-item>
            <p>Intrauterine growth restriction</p>
          </list-item>
          <list-item>
            <p>Hemorrhage</p>
          </list-item>
          <list-item>
            <p>Placental abruption</p>
          </list-item>
          <list-item>
            <p>Gestational diabetes</p>
          </list-item>
          <list-item>
            <p>Progressive heart failure</p>
          </list-item>
          <list-item>
            <p>Maternal or fetal death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37515.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations should include:</p>
        <list list-type="bullet">
          <list-item>
            <p>High-risk obstetrician</p>
          </list-item>
          <list-item>
            <p>Cardiology</p>
          </list-item>
          <list-item>
            <p>Perinatologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37515.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be made&#x000a0;aware of their cardiac conditions from the outset and allowed to be engaged in decision making throughout the process. It is of utmost importance to highlight the risks involved to the patient and the fetus. From the conception of pregnancy, mothers should receive counsel regarding risk factors attributed to cardiac disease of pregnancy. These risk factors include drug use, alcohol abuse, hypertension, diabetes mellitus, pre-existing heart disease, myocarditis, and familial heart disease of pregnancy.</p>
      </sec>
      <sec id="article-37515.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Each pregnancy requires a team of professionals working together to provide coordinated and effective care. This level of cohesion is even more necessary in pregnant patients with cardiac disease. Physicians play an essential role in distinguishing normal versus abnormal pregnancy states; this can be difficult to decipher regarding cardiac disease because often, pregnant females might exhibit symptoms of cardiac disease in a healthy pregnancy. Nurses have a vital role in the healthcare setting for pregnant patients with cardiac disease.&#x000a0; With the admission of these patients to the hospital, their nurses must be cognizant of the complex dynamics of pregnancy and especially when interventions may be necessary. Early recognition of disease states is essential to prevent worse outcomes for these patients. Pharmacists also have a unique role in the care of pregnant females with cardiac disease. A vast number of drugs and medications routinely&#x000a0;used at other times may be detrimental to pregnant women and/or their unborn children. Pharmacists have the unique role of being aware of these medications and interactions and recommending adjustments when needed. Lynch et al. highlighted the critical role of communication between physicians and pharmacists for the best outcomes of pregnancy.<xref ref-type="bibr" rid="article-37515.r47">[47]</xref>&#x000a0; The interprofessional team is an essential part of the healthcare system. The need for balanced coordination of care only expands in managing the pregnant patient through a safe pregnancy for the mother and child. [Level 5]</p>
      </sec>
      <sec id="article-37515.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37515&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37515">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/cardiac-disease-in-pregnancy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=37515">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/37515/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=37515">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-37515.s16">
        <title>References</title>
        <ref id="article-37515.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldstein</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Congenital and Acquired Valvular Heart Disease in Pregnancy.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <day>24</day>
            <volume>19</volume>
            <issue>10</issue>
            <fpage>96</fpage>
            <pub-id pub-id-type="pmid">28840470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkayam</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Goland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Silverside</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>High-Risk Cardiac Disease in Pregnancy: Part I.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2016</year>
            <month>Jul</month>
            <day>26</day>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>396</fpage>
            <page-range>396-410</page-range>
            <pub-id pub-id-type="pmid">27443437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ntusi</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Mayosi</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Aetiology and risk factors of peripartum cardiomyopathy: a systematic review.</article-title>
            <source>Int J Cardiol</source>
            <year>2009</year>
            <month>Jan</month>
            <day>09</day>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>168</fpage>
            <page-range>168-79</page-range>
            <pub-id pub-id-type="pmid">18722678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weintraub</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Semsarian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dilated cardiomyopathy.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Jul</month>
            <day>22</day>
            <volume>390</volume>
            <issue>10092</issue>
            <fpage>400</fpage>
            <page-range>400-414</page-range>
            <pub-id pub-id-type="pmid">28190577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pathak</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Shirodkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ruparelia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rajebahadur</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery disease in women.</article-title>
            <source>Indian Heart J</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>532</fpage>
            <page-range>532-538</page-range>
            <pub-id pub-id-type="pmid">28822527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>James</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Jamison</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Brancazio</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Swamy</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Acute myocardial infarction in pregnancy: a United States population-based study.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Mar</month>
            <day>28</day>
            <volume>113</volume>
            <issue>12</issue>
            <fpage>1564</fpage>
            <page-range>1564-71</page-range>
            <pub-id pub-id-type="pmid">16534011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashrafi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Heart Disease and Pregnancy.</article-title>
            <source>Cardiol Ther</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-173</page-range>
            <pub-id pub-id-type="pmid">28681178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>European Society of Gynecology (ESG)</collab>
              <collab>Association for European Paediatric Cardiology (AEPC)</collab>
              <collab>German Society for Gender Medicine (DGesGM)</collab>
              <name>
                <surname>Regitz-Zagrosek</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Blomstrom Lundqvist</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borghi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cifkova</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Foidart</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gibbs</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Gohlke-Baerwolf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gorenek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maas</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Morais</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Presbitero</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Schaufelberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seeland</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Torracca</surname>
                <given-names>L</given-names>
              </name>
              <collab>ESC Committee for Practice Guidelines</collab>
            </person-group>
            <article-title>ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).</article-title>
            <source>Eur Heart J</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>24</issue>
            <fpage>3147</fpage>
            <page-range>3147-97</page-range>
            <pub-id pub-id-type="pmid">21873418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Zamudio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coffin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Merouani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Osorio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Dahms</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schrier</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.</article-title>
            <source>Kidney Int</source>
            <year>1998</year>
            <month>Dec</month>
            <volume>54</volume>
            <issue>6</issue>
            <fpage>2056</fpage>
            <page-range>2056-63</page-range>
            <pub-id pub-id-type="pmid">9853271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lof</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olausson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bostrom</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Janerot-Sj&#x000f6;berg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sohlstrom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forsum</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, cardiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>678</fpage>
            <page-range>678-85</page-range>
            <pub-id pub-id-type="pmid">15755839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sciscione</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Ivester</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Largoza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shlossman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Colmorgen</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Acute pulmonary edema in pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>511</fpage>
            <page-range>511-5</page-range>
            <pub-id pub-id-type="pmid">12636955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McFaul</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Dornan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lamki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy complicated by maternal heart disease. A review of 519 women.</article-title>
            <source>Br J Obstet Gynaecol</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>95</volume>
            <issue>9</issue>
            <fpage>861</fpage>
            <page-range>861-7</page-range>
            <pub-id pub-id-type="pmid">3191059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Selzer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Risks of pregnancy in women with cardiac disease.</article-title>
            <source>JAMA</source>
            <year>1977</year>
            <month>Aug</month>
            <day>22</day>
            <volume>238</volume>
            <issue>8</issue>
            <fpage>892</fpage>
            <page-range>892-3</page-range>
            <pub-id pub-id-type="pmid">577983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valensise</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Vasapollo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Borzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arduini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Galante</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romanini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Maternal cardiac systolic and diastolic function: relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>487</fpage>
            <page-range>487-97</page-range>
            <pub-id pub-id-type="pmid">11005116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandey</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhawani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Majumadar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of maternal myocardial performance during normal pregnancy and post partum.</article-title>
            <source>Indian Heart J</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-7</page-range>
            <pub-id pub-id-type="pmid">21180037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Estensen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Beitnes</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Grindheim</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aaberge</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smiseth</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Henriksen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Aakhus</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Altered maternal left ventricular contractility and function during normal pregnancy.</article-title>
            <source>Ultrasound Obstet Gynecol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>659</fpage>
            <page-range>659-66</page-range>
            <pub-id pub-id-type="pmid">23001841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morales</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Painter</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siegfried</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hershberger</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.</article-title>
            <source>Circulation</source>
            <year>2010</year>
            <month>May</month>
            <day>25</day>
            <volume>121</volume>
            <issue>20</issue>
            <fpage>2176</fpage>
            <page-range>2176-82</page-range>
            <pub-id pub-id-type="pmid">20458009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arany</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Foo</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ruas</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bommi-Reddy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Girnun</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laznik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chinsomboon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rangwala</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Rosenzweig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spiegelman</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.</article-title>
            <source>Nature</source>
            <year>2008</year>
            <month>Feb</month>
            <day>21</day>
            <volume>451</volume>
            <issue>7181</issue>
            <fpage>1008</fpage>
            <page-range>1008-12</page-range>
            <pub-id pub-id-type="pmid">18288196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hameed</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ghamsary</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elkayam</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum.</article-title>
            <source>Clin Cardiol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>E60</fpage>
            <page-range>E60-2</page-range>
            <pub-id pub-id-type="pmid">19455566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehtoranta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Valta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aantaa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Perheentupa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Supraventricular tachycardia during pregnancy].</article-title>
            <source>Duodecim</source>
            <year>2016</year>
            <volume>132</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-5</page-range>
            <pub-id pub-id-type="pmid">26939491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Katou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ichinose</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nobe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yonemochi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyakawa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Saikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of new-onset ventricular arrhythmias in pregnancy.</article-title>
            <source>J Electrocardiol</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-53</page-range>
            <pub-id pub-id-type="pmid">15132369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romagano</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Qui&#x000f1;ones</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Ahnert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smulian</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Catecholaminergic Polymorphic Ventricular Tachycardia in Pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>127</volume>
            <issue>4</issue>
            <fpage>735</fpage>
            <page-range>735-739</page-range>
            <pub-id pub-id-type="pmid">26959204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyle</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The electrocardiographic ST segment in pregnancy.</article-title>
            <source>J Obstet Gynaecol Br Commonw</source>
            <year>1966</year>
            <month>Dec</month>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>986</fpage>
            <page-range>986-7</page-range>
            <pub-id pub-id-type="pmid">5927791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campos</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bocanegra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study.</article-title>
            <source>Int J Cardiol</source>
            <year>1993</year>
            <month>Jul</month>
            <day>15</day>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-72</page-range>
            <pub-id pub-id-type="pmid">8225661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Umar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amjedi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iorga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nadadur</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Regitz-Zagrosek</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Eghbali</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>New frontiers in heart hypertrophy during pregnancy.</article-title>
            <source>Am J Cardiovasc Dis</source>
            <year>2012</year>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>192</fpage>
            <page-range>192-207</page-range>
            <pub-id pub-id-type="pmid">22937489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hibbard</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Lindheimer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography.</article-title>
            <source>Obstet Gynecol</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>311</fpage>
            <page-range>311-6</page-range>
            <pub-id pub-id-type="pmid">10432149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boix</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zapater</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pic&#x000f3;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Teratogenicity with angiotensin II receptor antagonists in pregnancy.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>1029</fpage>
            <page-range>1029-31</page-range>
            <pub-id pub-id-type="pmid">16483184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thorne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>MacGregor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nelson-Piercy</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Risks of contraception and pregnancy in heart disease.</article-title>
            <source>Heart</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>92</volume>
            <issue>10</issue>
            <fpage>1520</fpage>
            <page-range>1520-5</page-range>
            <pub-id pub-id-type="pmid">16973809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sliwa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hilfiker-Kleiner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Petrie</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mebazaa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pieske</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Buchmann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Regitz-Zagrosek</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schaufelberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tavazzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Veldhuisen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Seferovic</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Elkayam</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pankuweit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Papp</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mouquet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <collab>Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy</collab>
            </person-group>
            <article-title>Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.</article-title>
            <source>Eur J Heart Fail</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>767</fpage>
            <page-range>767-78</page-range>
            <pub-id pub-id-type="pmid">20675664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silversides</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Colman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sermer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Cardiac risk in pregnant women with rheumatic mitral stenosis.</article-title>
            <source>Am J Cardiol</source>
            <year>2003</year>
            <month>Jun</month>
            <day>01</day>
            <volume>91</volume>
            <issue>11</issue>
            <fpage>1382</fpage>
            <page-range>1382-5</page-range>
            <pub-id pub-id-type="pmid">12767443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tafreshi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Beta-blocker therapy for valvular disorders.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2011</year>
            <month>May</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>241</fpage>
            <page-range>241-53</page-range>
            <pub-id pub-id-type="pmid">21714412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adamson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Nelson-Piercy</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Managing palpitations and arrhythmias during pregnancy.</article-title>
            <source>Heart</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>93</volume>
            <issue>12</issue>
            <fpage>1630</fpage>
            <page-range>1630-6</page-range>
            <pub-id pub-id-type="pmid">18003696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Use of medication for cardiovascular disease during pregnancy.</article-title>
            <source>Nat Rev Cardiol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>718</fpage>
            <page-range>718-29</page-range>
            <pub-id pub-id-type="pmid">26585398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bac</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Lotgering</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Verkaaik</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Deckers</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous coronary artery dissection during pregnancy and post partum.</article-title>
            <source>Eur Heart J</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <page-range>136-8</page-range>
            <pub-id pub-id-type="pmid">7737212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koul</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Hollander</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moskovits</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Frankel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Herrera</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-94</page-range>
            <pub-id pub-id-type="pmid">11146532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heefner</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Dissecting hematoma of the coronary artery. A possible complication of oral contraceptive therapy.</article-title>
            <source>JAMA</source>
            <year>1973</year>
            <month>Jan</month>
            <day>29</day>
            <volume>223</volume>
            <issue>5</issue>
            <fpage>550</fpage>
            <page-range>550-1</page-range>
            <pub-id pub-id-type="pmid">4739140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kachurovskaia</surname>
                <given-names>OS</given-names>
              </name>
            </person-group>
            <article-title>[Diagnosis of the extrathoracic forms of sarcoidosis].</article-title>
            <source>Vrach Delo</source>
            <year>1987</year>
            <month>Sep</month>
            <issue>9</issue>
            <fpage>71</fpage>
            <page-range>71-3</page-range>
            <pub-id pub-id-type="pmid">3424780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lane</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cartledge</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Successful surgical treatment of spontaneous coronary artery dissection.</article-title>
            <source>Curr Surg</source>
            <year>2001</year>
            <month>May</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>316</fpage>
            <page-range>316-318</page-range>
            <pub-id pub-id-type="pmid">11397493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martillotti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boehlen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Robert-Ebadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jastrow</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Righini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blondon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review.</article-title>
            <source>J Thromb Haemost</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>1942</fpage>
            <page-range>1942-1950</page-range>
            <pub-id pub-id-type="pmid">28805341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elkayam</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Acute myocardial infarction associated with pregnancy.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2008</year>
            <month>Jul</month>
            <day>15</day>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-80</page-range>
            <pub-id pub-id-type="pmid">18617065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phipps</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Prasanna</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brima</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Jim</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Jun</month>
            <day>06</day>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>1102</fpage>
            <page-range>1102-1113</page-range>
            <pub-id pub-id-type="pmid">27094609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amos</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Improved outcomes in peripartum cardiomyopathy with contemporary.</article-title>
            <source>Am Heart J</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>152</volume>
            <issue>3</issue>
            <fpage>509</fpage>
            <page-range>509-13</page-range>
            <pub-id pub-id-type="pmid">16923422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khairy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lee-Parritz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Economy</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Landzberg</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy outcomes in women with congenital heart disease.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Jan</month>
            <day>31</day>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-24</page-range>
            <pub-id pub-id-type="pmid">16449731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drenthen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>van Lottum</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Vliegen</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Moons</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ebels</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>van Veldhuisen</surname>
                <given-names>DJ</given-names>
              </name>
              <collab>ZAHARA Investigators</collab>
            </person-group>
            <article-title>Outcome of pregnancy in women with congenital heart disease: a literature review.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2007</year>
            <month>Jun</month>
            <day>19</day>
            <volume>49</volume>
            <issue>24</issue>
            <fpage>2303</fpage>
            <page-range>2303-11</page-range>
            <pub-id pub-id-type="pmid">17572244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burchill</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Lameijer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Grewal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ruys</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Kulikowski</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Burchill</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Oudijk</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Colman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Pieper</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Silversides</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome.</article-title>
            <source>Heart</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>101</volume>
            <issue>7</issue>
            <fpage>525</fpage>
            <page-range>525-9</page-range>
            <pub-id pub-id-type="pmid">25564557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ladner</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Danielsen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Acute myocardial infarction in pregnancy and the puerperium: a population-based study.</article-title>
            <source>Obstet Gynecol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>105</volume>
            <issue>3</issue>
            <fpage>480</fpage>
            <page-range>480-4</page-range>
            <pub-id pub-id-type="pmid">15738011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37515.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lynch</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Amoozegar</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>McClure</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Squiers</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Broussard</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Polen</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Gilboa</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Biermann</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.</article-title>
            <source>Qual Health Res</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>13</issue>
            <fpage>2071</fpage>
            <page-range>2071-2080</page-range>
            <pub-id pub-id-type="pmid">28974142</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
